IMU's " subsidiary " CHM, PH chairman and LC director, are currently world leader in establishing CAR-T antigen CD 17 as a validated target by having licenced it from Penn ( Uni Pennsylvania ). They also just signed a contract to secure manufacturing of the needed CAR-T cells.
That way, IMU is in some way involved in CAR-T with its own CDH-17 ( CHM's name for it ) soon starting Ph1. PH recently confirmed to me that, after succesfully validating CDH-17 and a successfully CD19/ CF33 combo CDH-17 could be trialed with CF33 too.
Still a bit of time away but you guys get the picture about what's unfolding here.
GLTA
IMU's " subsidiary " CHM, PH chairman and LC director, are...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
-0.007(8.97%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 7.8¢ | 8.0¢ | 7.0¢ | $4.930M | 66.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 571382 | 7.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 1102836 | 5 |
View Market Depth
| Last trade - 16.10pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.007 ( 10.7 %) |
||||
| Open | High | Low | Volume | ||
| 7.8¢ | 8.0¢ | 7.0¢ | 28787854 | ||
| Last updated 15.59pm 19/04/2024 ? | |||||
| IMU (ASX) Chart |